Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000897069-25-001355
Filing Date
2025-08-14
Accepted
2025-08-14 17:05:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5435
  Complete submission text file 0000897069-25-001355.txt   7455
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Subject) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-87181 | Film No.: 251220805
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5600 MARINER STREET SUITE 200 TAMPA FL 33609
Business Address 5600 MARINER STREET SUITE 200 TAMPA FL 33609 856-430-1991
KP Biotech Group LLC (Filed by) CIK: 0001998301 (see all company filings)

EIN.: 823889020 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SCHEDULE 13G/A